Sanofi recalls all Zantac 150mg products due to detected NDMA impurity, a potential risk for long-term health effects. Consumers should check product details and follow official instructions.
CGMP Deviations: Presence of NDMA impurity detected in product.
Sanofi is recalling all Zantac 150mg products because they contain NDMA impurity, which may pose health risks over time. This affects anyone who has taken the medication.
NDMA is a chemical that has been linked to potential health risks, including liver damage, when present in high amounts over time. The impurity was detected in the medication during manufacturing.
People who have taken Zantac 150mg tablets are affected. Those with pre-existing conditions or taking other medications may be at slightly higher risk.
Check for Zantac 150mg tablets with NDC code 05269-220-25. All lots of this product are affected.
Look for the NDC code 05269-220-25 on the product label to confirm it is recalled.
No, only Zantac 150mg tablets with NDC code 05269-220-25 are affected.
Check the product details and contact Sanofi for further instructions.
The recall is due to potential long-term health risks from NDMA impurity, not immediate injury risks.
We’ve drafted a message you can send Sanofi to request your refund or repair — edit it as you like.
Subject: Recall D-0537-2020 — Sanofi Sanofi Hello, I own a Sanofi that is covered by recall D-0537-2020 from Sanofi. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
